Piramal Pharma Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Sep-24 | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 |
|---|---|---|---|---|---|---|---|---|
| 2,242 | 2,204 | 2,754 | 1,934 | 2,044 | 2,140 | 2,752 | 2,270 | |
| 61 | 12 | 42 | 58 | 66 | 43 | 46 | 89 | |
| 2,200 | 2,167 | 2,540 | 2,110 | 2,170 | 2,246 | 2,593 | 2,386 | |
| 575 | 805 | 204 | 524 | 483 | 505 | 483 | 725 | |
| 395 | 161 | 547 | 343 | 375 | 377 | 336 | 420 | |
| −173 | −161 | 205 | −173 | −156 | −96 | 237 | −293 | |
| 560 | 556 | 612 | 619 | 611 | 600 | 586 | 676 | |
| 108 | 103 | 104 | 86 | 82 | 89 | 83 | 88 | |
| 192 | 197 | 243 | 197 | 203 | 213 | 218 | 224 | |
| 544 | 504 | 626 | 514 | 571 | 558 | 650 | 547 | |
| 403 | 350 | 603 | 186 | 224 | 198 | 331 | 285 | |
| 211 | 153 | 360 | −11 | 21 | −15 | 112 | 61 | |
| — | — | — | 21 | — | −41 | −176 | — | |
| 103 | 50 | 257 | −98 | −61 | −104 | 29 | −27 | |
| 98 | 63 | 119 | 3 | 53 | 42 | 52 | 62 | |
| 23 | 4 | 154 | −82 | −99 | −136 | −9 | −69 | |
| Financial ratios | ||||||||
| 17.96% | 15.87% | 21.90% | 9.61% | 10.97% | 9.25% | 12.02% | 12.54% | |
| 1.01% | 0.17% | 5.57% | -4.23% | -4.85% | -6.36% | -0.32% | -3.06% | |
| 0.17 | 0.03 | 1.16 | -0.62 | -0.75 | -1.03 | -0.07 | -0.52 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.